Zealand Pharma A/S EBITDA Margin 2018-2022 | ZEAL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Zealand Pharma A/S (ZEAL) over the last 10 years. The current EBITDA margin for Zealand Pharma A/S as of March 31, 2022 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2022-03-31 |
$0.04B |
$-0.17B |
-419.51% |
2021-12-31 |
$0.05B |
$-0.17B |
-357.45% |
2021-09-30 |
$0.05B |
$-0.18B |
-352.00% |
2021-06-30 |
$0.04B |
$-0.17B |
-411.90% |
2021-03-31 |
$0.06B |
$-0.13B |
-219.67% |
2020-12-31 |
$0.06B |
$-0.12B |
-214.55% |
2020-09-30 |
$0.05B |
$-0.09B |
-202.17% |
2020-06-30 |
$0.04B |
$-0.08B |
-213.16% |
2020-03-31 |
$0.01B |
$-0.09B |
-1175.00% |
2019-09-30 |
$0.01B |
$-0.08B |
-1333.33% |
2018-12-31 |
$0.01B |
$0.10B |
1716.67% |
2018-06-30 |
$0.01B |
$-0.06B |
-483.33% |
2018-03-31 |
$0.01B |
$-0.05B |
-425.00% |
2017-12-31 |
$0.02B |
$-0.04B |
-176.19% |